CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Avid Bioservices, Inc. - CDMO CFD

15.14
3.09%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.11
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 15.52
Open* 14.93
1-Year Change* -1.58%
Day's Range* 14.62 - 14.62
52 wk Range 11.3-32.51
Average Volume (10 days) 0.47248
Average Volume (3 months) 13.5755
Market Cap 915.727
P/E Ratio 10.6056
Shares Outstanding 62167500
Revenue 125.535
EPS 1.38889
Dividend (Yield %) N/A
Beta 1.7988
Next Earnings Date Dec 5, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 29, 2022 15.14 0.02 0.13% 15.12 15.33 14.55
Jun 28, 2022 15.52 -0.45 -2.82% 15.97 16.26 15.47
Jun 27, 2022 16.32 0.73 4.68% 15.59 16.50 15.32
Jun 24, 2022 15.57 0.03 0.19% 15.54 16.00 15.07
Jun 23, 2022 15.66 1.09 7.48% 14.57 15.71 14.57
Jun 22, 2022 14.62 0.72 5.18% 13.90 14.95 13.90
Jun 21, 2022 14.44 1.04 7.76% 13.40 14.72 13.40
Jun 17, 2022 13.30 0.73 5.81% 12.57 13.49 12.57
Jun 16, 2022 12.50 0.50 4.17% 12.00 12.58 11.85
Jun 15, 2022 12.54 0.43 3.55% 12.11 12.69 11.98
Jun 14, 2022 12.09 -0.01 -0.08% 12.10 12.29 11.79
Jun 13, 2022 12.03 -0.07 -0.58% 12.10 12.24 11.77
Jun 10, 2022 12.65 -0.33 -2.54% 12.98 13.16 12.57
Jun 9, 2022 13.34 -0.09 -0.67% 13.43 13.74 13.29
Jun 8, 2022 13.86 -0.51 -3.55% 14.37 14.53 13.82
Jun 7, 2022 14.35 1.18 8.96% 13.17 14.41 13.17
Jun 6, 2022 13.57 0.17 1.27% 13.40 13.62 13.29
Jun 3, 2022 13.37 0.13 0.98% 13.24 13.67 13.14
Jun 2, 2022 13.72 0.91 7.10% 12.81 13.87 12.81
Jun 1, 2022 13.39 0.09 0.68% 13.30 13.57 13.01

Avid Bioservices, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2017 2018 2019 2020 2021 2022
Total revenue 57.63 53.621 53.603 59.702 95.868 119.597
Revenue 57.63 53.621 53.603 59.702 95.868 119.597
Cost of Revenue, Total 38.259 56.545 46.379 55.77 66.561 82.949
Gross Profit 19.371 -2.924 7.224 3.932 29.307 36.648
Total Operating Expense 56.338 74.259 59.225 70.642 83.625 104.175
Selling/General/Admin. Expenses, Total 18.079 16.456 12.846 14.517 17.064 21.226
Unusual Expense (Income) 0 1.258 0 0.355 0 0
Operating Income 1.292 -20.638 -5.622 -10.94 12.243 15.422
Interest Income (Expense), Net Non-Operating 0.101 0.075 0.282 0.474 -1.031 -2.761
Net Income Before Taxes 1.393 -20.563 -5.34 -10.466 11.212 12.661
Net Income After Taxes 1.393 -20.563 -5.056 -10.466 11.212 127.672
Net Income Before Extra. Items 1.393 -20.563 -5.056 -10.466 11.212 127.672
Total Extraordinary Items -29.552 -1.25 0.841 0 0
Net Income -28.159 -21.813 -4.215 -10.466 11.212 127.672
Total Adjustments to Net Income -4.64 -4.686 -4.686 -4.686 -7.894 0
Income Available to Common Excl. Extra. Items -3.247 -25.249 -9.742 -15.152 3.318 127.672
Income Available to Common Incl. Extra. Items -32.799 -26.499 -8.901 -15.152 3.318 127.672
Diluted Net Income -32.799 -26.499 -8.901 -15.152 3.318 127.672
Diluted Weighted Average Shares 37.1095 47.063 55.9811 56.326 59.426 70.474
Diluted EPS Excluding Extraordinary Items -0.0875 -0.53649 -0.17402 -0.26901 0.05583 1.81162
Diluted Normalized EPS -0.0875 -0.50976 -0.17402 -0.2627 0.05583 1.81162
Q4 2021 Q1 2021 Q2 2021 Q3 2022 Q4 2022
Total revenue 27.606 30.754 26.109 31.508 31.226
Revenue 27.606 30.754 26.109 31.508 31.226
Cost of Revenue, Total 19.463 19.363 16.923 22.421 24.242
Gross Profit 8.143 11.391 9.186 9.087 6.984
Total Operating Expense 24.518 23.823 21.956 28.239 30.157
Selling/General/Admin. Expenses, Total 5.055 4.46 5.033 5.818 5.915
Unusual Expense (Income) 0 0
Operating Income 3.088 6.931 4.153 3.269 1.069
Interest Income (Expense), Net Non-Operating -1.097 -0.627 -0.631 -1.021 -0.482
Net Income Before Taxes 1.991 6.304 3.522 2.248 0.587
Net Income After Taxes 1.991 6.304 3.522 2.248 115.598
Net Income Before Extra. Items 1.991 6.304 3.522 2.248 115.598
Total Extraordinary Items 0
Net Income 1.991 6.304 3.522 2.248 115.598
Total Adjustments to Net Income -4.29 0 0 0 0
Income Available to Common Excl. Extra. Items -2.299 6.304 3.522 2.248 115.598
Income Available to Common Incl. Extra. Items -2.299 6.304 3.522 2.248 115.598
Diluted Net Income -2.299 6.304 3.522 2.248 115.598
Diluted Weighted Average Shares 60.841 63.571 63.602 63.872 90.763
Diluted EPS Excluding Extraordinary Items -0.03779 0.09916 0.05538 0.0352 1.27362
Diluted Normalized EPS -0.03779 0.09916 0.05538 0.0352 1.27362
Dividends per Share - Common Stock Primary Issue 0 0 0
  • Annual
  • Quarterly
2017 2018 2019 2020 2021 2022
Total Current Assets 89.874 67.827 51.318 59.763 207.804 180.023
Cash and Short Term Investments 46.799 42.265 32.351 36.262 169.915 126.166
Cash & Equivalents 46.799 42.265 32.351 36.262 169.915 126.166
Total Receivables, Net 7.742 3.754 11.701 11.906 24.954 25.916
Accounts Receivable - Trade, Net 7.274 3.539 11.701 11.906 24.954 25.916
Total Inventory 33.099 16.129 6.557 10.883 11.871 26.062
Prepaid Expenses 0.808 0.679 0.709 0.712 1.064 1.879
Other Current Assets, Total 1.426 5 0
Total Assets 118.112 95.76 78.395 107.62 265.51 429.843
Property/Plant/Equipment, Total - Net 26.045 26.479 25.625 47.205 56.146 129.761
Property/Plant/Equipment, Total - Gross 37.553 38.851 40.194 64.846 77.24 154.218
Accumulated Depreciation, Total -11.508 -12.372 -14.569 -17.641 -21.094 -24.457
Other Long Term Assets, Total 2.193 1.454 1.452 0.652 1.56 120.059
Total Current Liabilities 62.931 37.863 23.162 44.48 70.936 75.761
Accounts Payable 3 1.909 4.352 5.926 9.257 9.504
Accrued Expenses 5.055 2.564 3.54 4.247 10.149 11.387
Notes Payable/Short Term Debt 0 0 0 4.379 0 0
Other Current Liabilities, Total 54.876 33.39 15.27 29.928 51.53 54.365
Total Liabilities 64.53 40.022 25.327 65.724 187.774 255.317
Total Long Term Debt 0 0 0.093 0 96.949 141.67
Other Liabilities, Total 1.599 2.159 2.072 21.244 19.889 37.886
Total Equity 53.582 55.738 53.068 41.896 77.736 174.526
Preferred Stock - Non Redeemable, Net 0.002 0.002 0.002 0.002 0 0
Common Stock 0.044 0.055 0.056 0.056 0.061 0.062
Additional Paid-In Capital 590.971 614.81 613.615 612.909 637.534 605.841
Retained Earnings (Accumulated Deficit) -537.435 -559.129 -560.605 -571.071 -559.859 -431.377
Total Liabilities & Shareholders’ Equity 118.112 95.76 78.395 107.62 265.51 429.843
Total Common Shares Outstanding 44.014 55.6892 56.1357 56.483 61.069 61.807
Total Preferred Shares Outstanding 1.64776 1.64776 1.64776 1.648 0
Capital Lease Obligations 0.093 0 2.093
Long Term Debt 96.949 139.577
Current Port. of LT Debt/Capital Leases 0.505
Apr 2021 Jul 2021 Oct 2021 Jan 2022 Apr 2022
Total Current Assets 207.804 200.78 206.919 203.49 180.023
Cash and Short Term Investments 169.915 159.692 163.675 149.957 126.166
Cash & Equivalents 169.915 159.692 163.675 149.957 126.166
Total Receivables, Net 24.954 24.31 21.557 31.353 25.916
Accounts Receivable - Trade, Net 24.954 24.31 21.557 31.353 25.916
Total Inventory 11.871 15.242 20.31 21.054 26.062
Prepaid Expenses 1.064 1.536 1.377 1.126 1.879
Total Assets 265.51 270.531 301.627 314.095 429.843
Property/Plant/Equipment, Total - Net 56.146 67.446 90.719 106.903 129.761
Property/Plant/Equipment, Total - Gross 77.24 89.549 113.688 130.651 154.218
Accumulated Depreciation, Total -21.094 -22.103 -22.969 -23.748 -24.457
Other Long Term Assets, Total 1.56 2.305 3.989 3.702 120.059
Total Current Liabilities 70.936 63.248 69.528 77.302 75.761
Accounts Payable 9.257 9.611 10.005 6.456 9.504
Accrued Expenses 10.149 5.744 6.431 10.366 11.387
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 51.53 47.893 52.596 59.982 54.365
Total Liabilities 187.774 225.895 250.522 257.52 255.317
Total Long Term Debt 96.949 138.812 141.33 141.535 141.67
Long Term Debt 96.949 138.812 139.066 139.313 139.577
Other Liabilities, Total 19.889 23.835 39.664 38.683 37.886
Total Equity 77.736 44.636 51.105 56.575 174.526
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.061 0.061 0.062 0.062 0.062
Additional Paid-In Capital 637.534 597.32 600.266 603.488 605.841
Retained Earnings (Accumulated Deficit) -559.859 -552.745 -549.223 -546.975 -431.377
Total Liabilities & Shareholders’ Equity 265.51 270.531 301.627 314.095 429.843
Total Common Shares Outstanding 61.069 61.341 61.552 61.725 61.807
Total Preferred Shares Outstanding 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.496 0.498 0.505
Capital Lease Obligations 2.264 2.222 2.093
  • Annual
  • Quarterly
2017 2018 2019 2020 2021 2022
Net income/Starting Line -28.159 -21.813 -4.215 -10.466 11.212 127.672
Cash From Operating Activities -39.169 -25.992 -11.595 5.827 31.182 9.465
Cash From Operating Activities 2.463 2.562 2.746 3.091 3.453 4.48
Non-Cash Items 0.453 -7.517 -3.828 2.512 4.77 8.791
Cash Interest Paid 0.006 0.004 0.011 0.008 0.005 1.67
Changes in Working Capital -13.926 0.776 -6.298 10.69 11.747 -16.396
Cash From Investing Activities -3.059 -0.793 4.544 -3.812 -9.864 -56.411
Capital Expenditures -3.627 -3.793 -1.502 -3.812 -9.864 -56.411
Other Investing Cash Flow Items, Total 0.568 3 6.046 0 0
Cash From Financing Activities 28.165 22.251 -2.863 1.096 112.335 3.197
Total Cash Dividends Paid -4.279 -4.325 -4.325 -4.325 -4.455 0
Issuance (Retirement) of Stock, Net 32.583 26.756 1.536 1.12 -4.365 3.359
Issuance (Retirement) of Debt, Net -0.139 -0.18 -0.074 4.301 121.155 -0.162
Net Change in Cash -14.063 -4.534 -9.914 3.111 133.653 -43.749
Deferred Taxes -115.082
Cash Taxes Paid -0.064
Apr 2021 Jul 2021 Oct 2021 Jan 2022 Apr 2022
Net income/Starting Line 11.212 6.304 9.826 12.074 127.672
Cash From Operating Activities 31.182 -6.942 3.661 8.853 9.465
Cash From Operating Activities 3.453 1.009 2.036 3.06 4.48
Non-Cash Items 4.77 1.553 3.75 6.503 8.791
Changes in Working Capital 11.747 -15.808 -11.951 -12.784 -16.396
Cash From Investing Activities -9.864 -4.199 -11.824 -31.845 -56.411
Capital Expenditures -9.864 -4.199 -11.824 -31.845 -56.411
Other Investing Cash Flow Items, Total 0
Cash From Financing Activities 112.335 0.918 1.923 3.034 3.197
Total Cash Dividends Paid -4.455 0 0 0 0
Issuance (Retirement) of Stock, Net -4.365 0.918 1.923 3.034 3.359
Issuance (Retirement) of Debt, Net 121.155 0 0 0 -0.162
Net Change in Cash 133.653 -10.223 -6.24 -19.958 -43.749
Cash Interest Paid 0.914 1.67
Deferred Taxes -115.082
Cash Taxes Paid -0.064

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Avid Bioservices, Inc. Company profile

About Avid Bioservices Inc

Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

Financial summary

BRIEF: For the nine months ended 31 January 2022, Avid Bioservices Inc revenues increased 29% to $88.4M. Net income applicable to common stockholders increased from $5.6M to $12.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from $0.10 to $0.20.

Equity composition

Common Stock $.005 Par, 2/11, 325M auth., 67,885,811 issd., Insiders stakeholders own 7.94%. PO 12/8 2,150M Units (1 Common + 1Warrant) @ $.01 by Brooks, Hamburger & Satnick. 3/87, 1-for-100 reverse split. *FY'00 & '99 '01 financials are reclassified. FY '01 Q's are reclassified. 10/09, 1-for-5 reverse stock split.

Industry: Biopharmaceuticals

14191 Myford Road
TUSTIN
CALIFORNIA 92780
US

Income Statement

People also watch

US100

11,760.60 Price
-1.100% 1D Chg, %
Long position overnight fee -0.0166%
Short position overnight fee 0.0060%
Overnight fee time 22:00 (UTC)
Spread 3.0

Oil - Crude

76.62 Price
-1.870% 1D Chg, %
Long position overnight fee -0.0082%
Short position overnight fee -0.0061%
Overnight fee time 22:00 (UTC)
Spread 0.09

Natural Gas

7.20 Price
-5.490% 1D Chg, %
Long position overnight fee -0.1727%
Short position overnight fee 0.1266%
Overnight fee time 22:00 (UTC)
Spread 0.005

XRP/USD

0.40 Price
+0.340% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00262

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading